Clinical Trial Update: Long-term Persistence of Immunity Against Hepatitis B in 7-8 Years Old Children After Hepatitis B Vaccination. [Phase 4]

View source ↗

Summary

A phase 4 trial evaluating long-term persistence of immunity in 7- to 8-year-old children following hepatitis B vaccination.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Hepatitis B vaccine (Hepatitis B vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B Vaccine | Phase 4 | Status: COMPLETED | Results posted: 2009-05-27